Annual Accounts Receivable
$5.48 M
-$358.00 K-6.13%
December 31, 2023
Summary
- As of February 7, 2025, BIOL annual accounts receivable is $5.48 million, with the most recent change of -$358.00 thousand (-6.13%) on December 31, 2023.
- During the last 3 years, BIOL annual accounts receivable has risen by +$2.42 million (+79.24%).
Performance
BIOL Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
$3.53 M
-$1.31 M-27.10%
September 30, 2024
Summary
- As of February 7, 2025, BIOL quarterly accounts receivable is $3.53 million, with the most recent change of -$1.31 million (-27.10%) on September 30, 2024.
- Over the past year, BIOL quarterly accounts receivable has dropped by -$858.00 thousand (-19.55%).
Performance
BIOL Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
BIOL Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.1% | -19.6% |
| 3 y3 years | +79.2% | -19.6% |
| 5 y5 years | -50.7% | -19.6% |
BIOL Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.1% | -22.7% | -42.0% | at low |
| 5 y | 5-year | -37.4% | -44.2% | -59.7% | -13.3% |
| alltime | all time | -63.9% | -86.2% | -76.8% | -90.6% |
BIOLASE Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.53 M(-27.1%) |
| Jun 2024 | - | $4.84 M(-14.9%) |
| Mar 2024 | - | $5.69 M(+3.7%) |
| Dec 2023 | $5.48 M(-6.1%) | $5.48 M(+25.0%) |
| Sep 2023 | - | $4.39 M(-23.2%) |
| Jun 2023 | - | $5.72 M(+10.8%) |
| Mar 2023 | - | $5.16 M(-11.7%) |
| Dec 2022 | $5.84 M(+37.8%) | $5.84 M(+20.5%) |
| Sep 2022 | - | $4.85 M(-20.3%) |
| Jun 2022 | - | $6.08 M(+17.4%) |
| Mar 2022 | - | $5.18 M(+22.2%) |
| Dec 2021 | $4.24 M(+38.5%) | $4.24 M(+16.5%) |
| Sep 2021 | - | $3.64 M(-4.8%) |
| Jun 2021 | - | $3.82 M(+16.9%) |
| Mar 2021 | - | $3.27 M(+6.8%) |
| Dec 2020 | $3.06 M(-65.1%) | $3.06 M(-9.8%) |
| Sep 2020 | - | $3.39 M(-17.6%) |
| Jun 2020 | - | $4.12 M(-13.3%) |
| Mar 2020 | - | $4.75 M(-45.8%) |
| Dec 2019 | $8.76 M(-21.2%) | $8.76 M(+3.4%) |
| Sep 2019 | - | $8.47 M(-13.0%) |
| Jun 2019 | - | $9.74 M(-17.1%) |
| Mar 2019 | - | $11.74 M(+5.7%) |
| Dec 2018 | $11.11 M(+9.8%) | $11.11 M(-2.5%) |
| Sep 2018 | - | $11.40 M(+9.6%) |
| Jun 2018 | - | $10.40 M(+6.8%) |
| Mar 2018 | - | $9.74 M(-3.8%) |
| Dec 2017 | $10.12 M(+3.5%) | $10.12 M(+4.3%) |
| Sep 2017 | - | $9.71 M(-1.0%) |
| Jun 2017 | - | $9.80 M(+6.3%) |
| Mar 2017 | - | $9.22 M(-5.8%) |
| Dec 2016 | $9.78 M(+9.3%) | $9.78 M(-1.5%) |
| Sep 2016 | - | $9.94 M(-9.9%) |
| Jun 2016 | - | $11.04 M(+9.2%) |
| Mar 2016 | - | $10.11 M(+12.9%) |
| Dec 2015 | $8.95 M(-0.6%) | $8.95 M(-3.2%) |
| Sep 2015 | - | $9.24 M(-5.5%) |
| Jun 2015 | - | $9.78 M(-0.3%) |
| Mar 2015 | - | $9.81 M(+9.0%) |
| Dec 2014 | $9.00 M(-19.1%) | $9.00 M(-2.8%) |
| Sep 2014 | - | $9.26 M(+40.4%) |
| Jun 2014 | - | $6.60 M(-22.9%) |
| Mar 2014 | - | $8.56 M(-23.1%) |
| Dec 2013 | $11.13 M(-4.7%) | $11.13 M(+3.0%) |
| Sep 2013 | - | $10.80 M(-5.9%) |
| Jun 2013 | - | $11.48 M(+7.8%) |
| Mar 2013 | - | $10.64 M(-8.9%) |
| Dec 2012 | $11.68 M | $11.68 M(+13.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $10.31 M(+7.7%) |
| Jun 2012 | - | $9.58 M(+6.6%) |
| Mar 2012 | - | $8.98 M(+0.9%) |
| Dec 2011 | $8.90 M(+167.2%) | $8.90 M(+10.2%) |
| Sep 2011 | - | $8.07 M(+26.2%) |
| Jun 2011 | - | $6.40 M(+7.2%) |
| Mar 2011 | - | $5.97 M(+79.1%) |
| Dec 2010 | $3.33 M(-21.2%) | $3.33 M(+16.4%) |
| Sep 2010 | - | $2.86 M(+70.8%) |
| Jun 2010 | - | $1.68 M(+63.9%) |
| Mar 2010 | - | $1.02 M(-75.8%) |
| Dec 2009 | $4.23 M(+12.5%) | $4.23 M(+29.1%) |
| Sep 2009 | - | $3.27 M(+29.0%) |
| Jun 2009 | - | $2.54 M(+46.9%) |
| Mar 2009 | - | $1.73 M(-54.0%) |
| Dec 2008 | $3.76 M(-66.6%) | $3.76 M(-21.6%) |
| Sep 2008 | - | $4.79 M(-10.5%) |
| Jun 2008 | - | $5.35 M(-47.5%) |
| Mar 2008 | - | $10.19 M(-9.5%) |
| Dec 2007 | $11.27 M(-25.8%) | $11.27 M(+50.3%) |
| Sep 2007 | - | $7.50 M(-35.6%) |
| Jun 2007 | - | $11.65 M(-5.2%) |
| Mar 2007 | - | $12.29 M(-19.1%) |
| Dec 2006 | $15.19 M(+80.8%) | $15.19 M(+49.7%) |
| Sep 2006 | - | $10.15 M(+34.3%) |
| Jun 2006 | - | $7.56 M(-24.1%) |
| Mar 2006 | - | $9.95 M(+18.4%) |
| Dec 2005 | $8.40 M(-12.8%) | $8.40 M(+33.9%) |
| Sep 2005 | - | $6.28 M(-16.6%) |
| Jun 2005 | - | $7.53 M(-40.0%) |
| Mar 2005 | - | $12.55 M(+30.3%) |
| Dec 2004 | $9.63 M(+67.0%) | $9.63 M(+52.8%) |
| Sep 2004 | - | $6.30 M(-28.3%) |
| Jun 2004 | - | $8.79 M(+41.7%) |
| Mar 2004 | - | $6.21 M(+7.5%) |
| Dec 2003 | $5.77 M(+15.8%) | $5.77 M(-22.0%) |
| Sep 2003 | - | $7.40 M(+37.9%) |
| Jun 2003 | - | $5.37 M(+44.8%) |
| Mar 2003 | - | $3.71 M(-25.6%) |
| Dec 2002 | $4.98 M(+137.9%) | $4.98 M(+43.3%) |
| Sep 2002 | - | $3.48 M(+27.8%) |
| Jun 2002 | - | $2.72 M(+12.1%) |
| Mar 2002 | - | $2.43 M(+15.9%) |
| Dec 2001 | $2.10 M(+176.4%) | $2.10 M(+66.5%) |
| Sep 2001 | - | $1.26 M(+279.5%) |
| Jun 2001 | - | $331.50 K(-69.6%) |
| Mar 2001 | - | $1.09 M(+44.0%) |
| Dec 2000 | $758.00 K | $758.00 K |
FAQ
- What is BIOLASE annual accounts receivable?
- What is the all time high annual accounts receivable for BIOLASE?
- What is BIOLASE annual accounts receivable year-on-year change?
- What is BIOLASE quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for BIOLASE?
- What is BIOLASE quarterly accounts receivable year-on-year change?
What is BIOLASE annual accounts receivable?
The current annual accounts receivable of BIOL is $5.48 M
What is the all time high annual accounts receivable for BIOLASE?
BIOLASE all-time high annual accounts receivable is $15.19 M
What is BIOLASE annual accounts receivable year-on-year change?
Over the past year, BIOL annual accounts receivable has changed by -$358.00 K (-6.13%)
What is BIOLASE quarterly accounts receivable?
The current quarterly accounts receivable of BIOL is $3.53 M
What is the all time high quarterly accounts receivable for BIOLASE?
BIOLASE all-time high quarterly accounts receivable is $15.19 M
What is BIOLASE quarterly accounts receivable year-on-year change?
Over the past year, BIOL quarterly accounts receivable has changed by -$858.00 K (-19.55%)